Based on the abovementioned findings, we speculated that PAR-1 activation might initiate PI3K/Akt signaling and phosphorylate downstream MAPK and NF-κB targets, thereby amplifying the inflammatory response in lung IR injury. This evidence concerns the gene NFKB1 and medical procedure.